Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: J Mol Cell Cardiol. 2011 Jul 28;51(5):740–748. doi: 10.1016/j.yjmcc.2011.07.018

Figure 5.

Figure 5

PKA inhibition by a specific PKA peptide inhibitor (PKI 14–22 Amide) decreases SANC O2 consumption (n=5) (A) and representative example of mitochondrial flavoprotein fluorescence trace (B) indicative of net reduction of flavoprotein pool. Washout of PKI reverse this effect. *p<0.05 vs. control.